Larisa Chisholm

Larisa is an experienced life science executive with a passion for the development and commercialisation of Australian technologies. She has broad cross-functional expertise as a result of working in companies spanning ASX listed, not-for-profit, academic and start-up ecosystems.

​Working for more than 14 years with ASX listed Immutep (formerly Prima BioMed), Larisa has significant experience aligning research, clinical, manufacturing and commercial strategies for peptide vaccine development.

​Larisa enjoys working with various industry organisations, not-for-profits and start-ups to advance the education and development of aspiring students, scientists and up and coming entrepreneurs, particularly women. She is a mentor for the Life Science Springboard Program in Australia, a member of the RMIT Biomedical Science Industry Advisory Committee and an industry advisory committee member for Central Pharmacy Logistics.

​Larisa has a Bachelor of Science (Honours) and MBA from La Trobe University and is a graduate of the Australian Institute of Company Directors.